Dose Finding Consortium (DFC)
Research Areas
At a Glance
- Status: Completed Consortium
- Year Launched: 2012
- Initiating Organization: Cytel
- Initiator Type: Industry
- No disease focus
- Location: North America
Abstract
Mission
The Dose Finding Consortium’s goals are to move the state-of-the-art forward in identifying optimal doses; to encode those practices into commercial validated software; to ease regulatory acceptance with more innovative methods — including adaptive trials — and apply them in practice more quickly.
Consortium History
This cooperative forum, initiated by Cytel in November 2012, addresses the gap left after Pharmaceutical Research and Manufacturers of America (PhRMA) discontinued its Working Group on Adaptive Dose-Ranging Studies in 2011.
Other website |
Sponsors & Partners
Michael Weitz
Director of Marketing
phone: 617-661-2011
Cytel |